Jayamas Medica Industri
PT Jayamas Medica Industri Tbk manufactures and sells medical devices in Indonesia, the United States of America, and South America. The company operates through three segments: Manufacturing, Distribution, and Retail. It offers medical disposables and consumables comprising medical gloves, syringes, masks, gauze, bandages, urine bag, foley catheter, alcoholic tissue, etc.; antiseptic and disinfe… Read more
Jayamas Medica Industri (OMED) - Total Assets
Latest total assets as of September 2025: Rp3.03 Trillion IDR
Based on the latest financial reports, Jayamas Medica Industri (OMED) holds total assets worth Rp3.03 Trillion IDR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Jayamas Medica Industri - Total Assets Trend (2019–2024)
This chart illustrates how Jayamas Medica Industri’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Jayamas Medica Industri - Asset Composition Analysis
Current Asset Composition (December 2024)
Jayamas Medica Industri's total assets of Rp3.03 Trillion consist of 80.0% current assets and 20.0% non-current assets.
| Asset Category | Amount (IDR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp736.73 Billion | 43.4% |
| Accounts Receivable | Rp268.56 Billion | 9.5% |
| Inventory | Rp639.98 Billion | 22.7% |
| Property, Plant & Equipment | Rp473.14 Billion | 16.8% |
| Intangible Assets | Rp23.64 Billion | 0.8% |
| Goodwill | Rp0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Jayamas Medica Industri's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Jayamas Medica Industri's current assets represent 80.0% of total assets in 2024, a decrease from 83.6% in 2019.
- Cash Position: Cash and equivalents constituted 43.4% of total assets in 2024, down from 47.8% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2019.
- Asset Diversification: The largest asset category is cash and equivalents at 43.4% of total assets.
Jayamas Medica Industri Competitors by Total Assets
Key competitors of Jayamas Medica Industri based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Jayamas Medica Industri - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Jayamas Medica Industri generates 0.67x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Jayamas Medica Industri generates $ 11.39 in net profit.
Jayamas Medica Industri - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 13.93 | 7.22 | 3.21 |
| Quick Ratio | 9.64 | 5.13 | 2.34 |
| Cash Ratio | 4.04 | 1.81 | 0.00 |
| Working Capital | Rp2.16 Trillion | Rp 1.91 Trillion | Rp 1.05 Trillion |
Jayamas Medica Industri - Advanced Valuation Insights
This section examines the relationship between Jayamas Medica Industri's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.59 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 9.4% |
| Total Assets | Rp2.83 Trillion |
| Market Capitalization | $62.25 Million USD |
Valuation Analysis
Below Book Valuation: The market values Jayamas Medica Industri's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Jayamas Medica Industri's assets grew by 9.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Jayamas Medica Industri (2019–2024)
The table below shows the annual total assets of Jayamas Medica Industri from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Rp2.83 Trillion | +9.45% |
| 2023-12-31 | Rp2.58 Trillion | +2.96% |
| 2022-12-31 | Rp2.51 Trillion | +45.23% |
| 2021-12-31 | Rp1.73 Trillion | +21.87% |
| 2020-12-31 | Rp1.42 Trillion | +113.96% |
| 2019-12-31 | Rp662.07 Billion | -- |